Preeclampsia (PE) is an extremely serious condition in pregnant women and the leading cause of maternal and fetal morbidity and mortality. Despite active research, the etiological factors of this disorder remain elusive. The increased release of 15-hydroxyeicosatetraenoic acid (15-HETE) in the placenta of preeclamptic patients has been studied, but its exact role in PE pathogenesis remains unknown. Mounting evidence shows that PE is associated with placental hypoxia, impaired placental angiogenesis, and endothelial dysfunction. In this study, we confirmed the upregulated expression of hypoxia-inducible factor 1α (HIF-1α) and 15-lipoxygenase-1/2 (15-LO-1/2) in patients with PE. Production of the arachidonic acid metabolite, 15-HETE, also increased in the preeclamptic placenta, which suggests enhanced activation of the HIF-1α–15-LO–15-HETE axis. Furthermore, this study is the first to show that the umbilical cord of preeclamptic women contains significantly higher serum concentrations of 15-HETE than that of healthy pregnant women. The results also show that expression of 15-LO-1/2 is upregulated in both human umbilical vein endothelial cells (HUVECs) collected from preeclamptic women and in those cultured under hypoxic conditions. Exogenous 15-HETE promotes the migration of HUVECs and in vitro tube formation and promotes cell cycle progression from the G0/G1 phase to the G2/M + S phase, whereas the 15-LO inhibitor, NDGA, suppresses these effects. The HIF-1α/15-LO/15-HETE pathway is therefore significantly associated within the pathology of PE.
References
[1]
MacKay AP, Berg CJ, Atrash HK (2001) Pregnancy-related mortality from preeclampsia and eclampsia. Obstet Gynecol 97: 533–538. doi: 10.1016/s0029-7844(00)01223-0
[2]
Roberts JM (1998) Endothelial dysfunction in preeclampsia. Semin Reprod Endocrinol 16: 5–15. doi: 10.1055/s-2007-1016248
[3]
Redman CW, Sargent IL (2005) Latest advances in understanding preeclampsia. Science 308: 1592–1594. doi: 10.1126/science.1111726
[4]
Young BC, Levine RJ, Karumanchi SA (2010) Pathogenesis of preeclampsia. Annu Rev Pathol 5: 173–192. doi: 10.1146/annurev-pathol-121808-102149
[5]
Levine RJ, Maynard SE, Qian C, Lim KH, England LJ, et al. (2004) Circulating angiogenic factors and the risk of preeclampsia. N Engl J Med 350: 672–683. doi: 10.1056/nejmoa031884
[6]
Wang A, Rana S, Karumanchi SA (2009) Preeclampsia: the role of angiogenic factors in its pathogenesis. Physiology (Bethesda) 24: 147–158. doi: 10.1152/physiol.00043.2008
[7]
Sankar KD, Bhanu PS, Kiran S, Ramakrishna BA, Shanthi V (2012) Vasculosyncytial membrane in relation to syncytial knots complicates the placenta in preeclampsia: a histomorphometrical study. Anat Cell Biol 45: 86–91. doi: 10.5115/acb.2012.45.2.86
[8]
Egbor M, Ansari T, Morris N, Green CJ, Sibbons PD (2006) Morphometric placental villous and vascular abnormalities in early- and late-onset pre-eclampsia with and without fetal growth restriction. BJOG 113: 580–589. doi: 10.1111/j.1471-0528.2006.00882.x
[9]
Caniggia I, Winter J, Lye SJ, Post M (2000) Oxygen and placental development during the first trimester: implications for the pathophysiology of pre-eclampsia. Placenta 21 Suppl A:S25–S30.
[10]
Myatt L (2006) Placental adaptive responses and fetal programming. J Physiol 572: 25–30. doi: 10.1113/jphysiol.2006.104968
[11]
Pugh CW, Ratcliffe PJ (2003) Regulation of angiogenesis by hypoxia: role of the HIF system. Nat Med 9: 677–684. doi: 10.1038/nm0603-677
[12]
Foidart JM, Schaaps JP, Chantraine F, Munaut C, Lorquet S (2009) Dysregulation of anti-angiogenic agents (sFlt-1, PLGF, and sEndoglin) in preeclampsia-a step forward but not the definitive answer. J Reprod Immunol 82: 106–111. doi: 10.1016/j.jri.2009.09.001
[13]
Laresgoiti-Servitje E, Gomez-Lopez N (2012) The pathophysiology of preeclampsia involves altered levels of angiogenic factors promoted by hypoxia and autoantibody-mediated mechanisms. Biol Reprod 87: 36. doi: 10.1095/biolreprod.112.099861
[14]
Sela S, Itin A, Natanson-Yaron S, Greenfield C, Goldman-Wohl D, et al. (2008) A novel human-specific soluble vascular endothelial growth factor receptor 1: cell-type-specific splicing and implications to vascular endothelial growth factor homeostasis and preeclampsia. Circ Res 102: 1566–1574. doi: 10.1161/circresaha.108.171504
[15]
Maynard SE, Min JY, Merchan J, Lim KH, Li J, et al. (2003) Excess placental soluble fms-like tyrosine kinase 1 (sFlt1) may contribute to endothelial dysfunction, hypertension, and proteinuria in preeclampsia. J Clin Invest 111: 649–658. doi: 10.1172/jci200317189
[16]
Nevo O, Soleymanlou N, Wu Y, Xu J, Kingdom J, et al. (2006) Increased expression of sFlt-1 in in vivo and in vitro models of human placental hypoxia is mediated by HIF-1. Am J Physiol Regul Integr Comp Physiol 291: R1085–R1093. doi: 10.1152/ajpregu.00794.2005
[17]
Tang N, Wang L, Esko J, Giordano FJ, Huang Y, et al. (2004) Loss of HIF-1alpha in endothelial cells disrupts a hypoxia-driven VEGF autocrine loop necessary for tumorigenesis. Cancer Cell 6: 485–495. doi: 10.1016/j.ccr.2004.09.026
[18]
McKeeman GC, Ardill JE, Caldwell CM, Hunter AJ, McClure N (2004) Soluble vascular endothelial growth factor receptor-1 (sFlt-1) is increased throughout gestation in patients who have preeclampsia develop. Am J Obstet Gynecol 191: 1240–1246. doi: 10.1016/j.ajog.2004.03.004
[19]
Johnson RD, Polakoski KL, Huang X, Sadovsky Y, Nelson DM (1998) The release of 15-hydroxyeicosatetraenoic acid by human placental trophoblast is increased in preeclampsia. Am J Obstet Gynecol 178: 54–58. doi: 10.1016/s0002-9378(98)70626-x
[20]
Srivastava K, Kundumani-Sridharan V, Zhang B, Bajpai AK, Rao GN (2007) 15(S)-hydroxyeicosatetraenoic acid-induced angiogenesis requires STAT3-dependent expression of VEGF. Cancer Res 67: 4328–4336. doi: 10.1158/0008-5472.can-06-3594
[21]
Wang Y, Zhu D, An Y, Sun J, Cai L, et al. (2012) Preeclampsia activates 15-lipoxygenase and its metabolite 15-hydroxyeicosatetraenoic acid enhances constriction in umbilical arteries. Prostaglandins Leukot Essent Fatty Acids 86: 79–84. doi: 10.1016/j.plefa.2011.10.006
[22]
Karthikeyan VJ, Lip GY (2011) Endothelial damage/dysfunction and hypertension in pregnancy. Front Biosci (Elite Ed) 3: 1100–1118. doi: 10.2741/314
[23]
Granger JP, Alexander BT, Llinas MT, Bennett WA, Khalil RA (2001) Pathophysiology of hypertension during preeclampsia linking placental ischemia with endothelial dysfunction. Hypertension 38: 718–722. doi: 10.1161/01.hyp.38.3.718
[24]
Drost JT, Maas AH, van Eyck J, van der Schouw YT (2010) Preeclampsia as a female-specific risk factor for chronic hypertension. Maturitas 67: 321–326. doi: 10.1016/j.maturitas.2010.08.002
[25]
Warrington JP, George EM, Palei AC, Spradley FT, Granger JP (2013) Recent advances in the understanding of the pathophysiology of preeclampsia. Hypertension 62: 666–673. doi: 10.1161/hypertensionaha.113.00588
[26]
Shenoy V, Kanasaki K, Kalluri R (2010) Pre-eclampsia: connecting angiogenic and metabolic pathways. Trends Endocrinol Metab 21: 529–536. doi: 10.1016/j.tem.2010.05.002
[27]
Iwagaki S, Yokoyama Y, Tang L, Takahashi Y, Nakagawa Y, et al. (2004) Augmentation of leptin and hypoxia-inducible factor 1alpha mRNAs in the pre-eclamptic placenta. Gynecol Endocrinol 18: 263–268. doi: 10.1080/0951359042000196277
[28]
Ashur-Fabian O, Yerushalmi GM, Mazaki-Tovi S, Steinberg DM, Goldshtein I, et al. (2012) Cell free expression of hif1α and p21 in maternal peripheral blood as a marker for preeclampsia and fetal growth restriction. PLoS One 7: e37273. doi: 10.1371/journal.pone.0037273
[29]
Caniggia I, Mostachfi H, Winter J, Gassmann M, Lye SJ, et al. (2000) Hypoxia-inducible factor-1 mediates the biological effects of oxygen on human trophoblast differentiation through TGFbeta(3). J Clin Invest 105: 577–587. doi: 10.1172/jci8316
[30]
Yao L, Nie X, Shi S, Song S, Hao X, et al. (2012) Reciprocal regulation of HIF-1α and 15-LO/15-HETE promotes anti-apoptosis process in pulmonary artery smooth muscle cells during hypoxia. Prostaglandins Other Lipid Mediat 99: 96–106. doi: 10.1016/j.prostaglandins.2012.09.001
[31]
Semenza GL (2001) Hypoxia-inducible factor 1: control of oxygen homeostasis in health and disease. Pediatr Res 49: 614–617. doi: 10.1203/00006450-200105000-00002
[32]
Sane DC, Anton L, Brosnihan KB (2004) Angiogenic growth factors and hypertension. Angiogenesis 7: 193–201. doi: 10.1007/s10456-004-2699-3
[33]
Freeman M (2000) Feedback control of intercellular signalling in development. Nature 408: 313–319. doi: 10.1038/35042500
[34]
Kleinrouweler CE, Wiegerinck MM, Ris-Stalpers C, Bossuyt PM, van der Post JA, et al. (2012) Accuracy of circulating placental growth factor, vascular endothelial growth factor, soluble fms-like tyrosine kinase 1 and soluble endoglin in the prediction of pre-eclampsia: a systematic review and meta-analysis. BJOG. 119: 778–787. doi: 10.1111/j.1471-0528.2012.03311.x
[35]
Myers JE, Kenny LC, McCowan LM, Chan EH, Dekker GA, et al. (2013) Angiogenic factors combined with clinical risk factors to predict preterm pre-eclampsia in nulliparous women: a predictive test accuracy study. BJOG 120: 1215–1223. doi: 10.1111/1471-0528.12195
[36]
Jaffe EA, Nachman RL, Becker CG, Minick CR (1973) Culture of human endothelial cells derived from umbilical veins. Identification by morphologic and immunologic criteria. J Clin Invest 52: 2745–2756. doi: 10.1172/jci107470
[37]
Lampugnani MG, Corada M, Caveda L, Breviario F, Ayalon O, et al. (1995) The molecular organization of endothelial cell to cell junctions: differential association of plakoglobin, beta-catenin, and alpha-catenin with vascular endothelial cadherin (VE-cadherin). J Cell Biol 129: 203–217. doi: 10.1083/jcb.129.1.203
[38]
Reilly KB, Srinivasan S, Hatley ME, Patricia MK, Lannigan J, et al. (2004) 12/15-Lipoxygenase activity mediates inflammatory monocyte/endothelial interactions and atherosclerosis in vivo. J Biol Chem 279: 9440–9450. doi: 10.1074/jbc.m303857200
[39]
Ma J, Zhang L, Han W, Shen T, Ma C, et al. (2012) Activation of JNK/c-Jun is required for the proliferation, survival, and angiogenesis induced by EET in pulmonary artery endothelial cells. J Lipid Res 53: 1093–1105. doi: 10.1194/jlr.m024398
